Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2020
Source ID
10.1016/s1473-3099(19)30614-0

Entities

People

  • Amara Luckay
  • Ayuko Ota-setlik
  • Cheryl S Gerardi
  • David K Clarke
  • Demetrius Matassov
  • Janice M. Rusnak
  • John H. Eldridge
  • Lucy A. Ward
  • Luz Hermida
  • Marc Tremblay
  • Michael A. Egan
  • Rong Xu
  • Susan E Witko
  • Susan Sciotto-brown
  • Terry Higgins
  • Theresa E Latham
  • Tracy Chen

Organizations

  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology